Karai, E.; Szebényi, K.; Windt, T.; Fehér, S.; Szendi, E.; Dékay, V.; Vajdovich, P.; Szakács, G.; Füredi, A.
Celecoxib Prevents Doxorubicin-Induced Multidrug Resistance in Canine and Mouse Lymphoma Cell Lines. Cancers 2020, 12, 1117.
https://doi.org/10.3390/cancers12051117
AMA Style
Karai E, Szebényi K, Windt T, Fehér S, Szendi E, Dékay V, Vajdovich P, Szakács G, Füredi A.
Celecoxib Prevents Doxorubicin-Induced Multidrug Resistance in Canine and Mouse Lymphoma Cell Lines. Cancers. 2020; 12(5):1117.
https://doi.org/10.3390/cancers12051117
Chicago/Turabian Style
Karai, Edina, Kornélia Szebényi, TÃmea Windt, Sára Fehér, Eszter Szendi, Valéria Dékay, Péter Vajdovich, Gergely Szakács, and András Füredi.
2020. "Celecoxib Prevents Doxorubicin-Induced Multidrug Resistance in Canine and Mouse Lymphoma Cell Lines" Cancers 12, no. 5: 1117.
https://doi.org/10.3390/cancers12051117
APA Style
Karai, E., Szebényi, K., Windt, T., Fehér, S., Szendi, E., Dékay, V., Vajdovich, P., Szakács, G., & Füredi, A.
(2020). Celecoxib Prevents Doxorubicin-Induced Multidrug Resistance in Canine and Mouse Lymphoma Cell Lines. Cancers, 12(5), 1117.
https://doi.org/10.3390/cancers12051117